Ken Griffin Lixte Biotechnology Hldgs Inc Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lixte Biotechnology Hldgs Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 28,141 shares of LIXTW stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,141
Previous 32,122
12.39%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions